NOVAVAX INC — Form SCHEDULE 13D/A
Filed October 16, 2026 · analyzed by the Ownership Agent
SCHEDULE 13D/A
— Neutral
significance 12/100
What the filing says
Shah Capital Management filed an amended Schedule 13D/A for Novavax Inc on October 16, 2026. The filing document itself contains no substantive disclosures of beneficial ownership changes, counterparties, dollar amounts, share counts, dates of transactions, or specifics of what changed. The amendment appears administrative in nature with no material information provided in the accessible text.
Why this rating
No material transaction details disclosed; appears routine 13D amendment filing with no quantified changes or events described.
See more from October 16, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.